- Meeting abstract
- Open Access
The way to a design space for an animal cell culture process according to Quality by Design (QbD)
© Puskeiler et al; licensee BioMed Central Ltd. 2011
- Published: 22 November 2011
- Design Space
- Risk Priority Number
- Cell Culture Process
- Critical Quality Attribute
- Standard Deviation Range
The strategy of implementation of the QbD (Quality by design) approach in upstream processing of therapeutic proteins consists of the identification of critical process parameters (CPPs) that have a statistically significant influence on the critical quality attributes (CQAs) of a specific process. By applying the acceptance criteria to the CQAs, proven acceptable ranges (PARs) for the CPPs can be deduced from experimental data. The multidimensional combination of these ranges form the design space and thus assures the quality of the product.
The QbD approach according to the ICH guidelines Q8, Q9 and Q10 may be subdivided in the work packages scale down model qualification, risk analysis, process characterization and range studies. The foundation of the QbD approach is represented by the scale down model. Several different scale down criteria were applied and adapted until a satisfactory match of scale down to commercial scale data was achieved. The scale down model is then used to investigate cause effect relationships between process parameters and quality attributes of the production process.
Since a standard cell culture process from thawing of the vial up to the final production fermenter can comprise up to 100 process parameters, a risk based approach is helpful to filter the most important ones. Those parameters are then experimentally investigated to verify their criticality for the quality attributes of the process. This approach relies on design of experiment (DoE) to reduce the number of required experiments to a manageable number while maintaining meaningful results. During the range studies, those critical parameters will be investigated with the help of a high resolution DoE matrix in order to be able to reveal possible interactions and higher order effects.
Based on development data a scale down model at 2 L scale was established. Predefined scale down criteria (power input, volumetric aeration rate, tip speed) were applied while taking the specific clone properties into account. The qualification of the scale down model was carried out by considering an acceptance criteria for several critical quality attributes and key performance indicators for at least three scale down fermentation runs. The acceptance criteria consisted of matching the 2-fold standard deviation range with the mean of the small scale data and the 3-fold standard deviation range with individual data points.
Being confronted with a large number of process parameters, risk assessment tools are used to focus the experimental efforts on the most relevant parameters. A Failure Mode and Effects Analysis (FMEA) based tool was applied to rate hypothetical deviations of a parameter from a previously defined observation range. The hypothetical deviation is rated by its severity, occurrence and detectability yielding a ranking of all parameters according to their risk priority number.
The results of that work package allowed to eliminate some process parameters from further experimentation due to their lack of significance and/or relevance. The resulting parameters were investigated in a second round of multivariate experimentation with a central composite design aiming at the definition of the unit operation design space. The higher resolution models were then subsequently used to define the design space mathematically. To that aim, each quality attribute was evaluated with its own optimized model only covering significant terms.
A fully representative view of the 4-dimensional design space can thus be achieved if all possible permutations of the external and internal axes is shown.
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.